NEW YORK, Jan. 13 - Beckman Coulter has consolidated its life-science and specialty-testing divisions into one unit called biomedical research, the company said late last week.
Elias Caro, vice president for clinical diagnostics product development centers and strategic marketing, has been named president of the new division.
George Bers, who ran the life science division, will become VP of systems biology, which was created "to strengthen the company's presence in genomics, proteomics and cellomics research." Ed Vivanco, Bers' counterpart at the specialty-testing unit, will become VP of operations, Beckman said.
"In order for us to leverage our technologies and products across the entire customer base of life science and clinical research, it is important that we optimize the relationship between those two areas of the business," president and CEO John Wareham said.
Caro, who will report to Wareham, will have "full accountability for strategy and profitability, including all activities related to creating value for life science research and clinical research customers," according to a company statement.